Free Trial

Beyond Air (XAIR) Competitors

Beyond Air logo
$0.49 -0.03 (-5.75%)
(As of 11/20/2024 ET)

XAIR vs. DRIO, PAVM, SRTS, TLSI, TELA, GUTS, FONR, EDAP, LNSR, and VANI

Should you be buying Beyond Air stock or one of its competitors? The main competitors of Beyond Air include DarioHealth (DRIO), PAVmed (PAVM), Sensus Healthcare (SRTS), TriSalus Life Sciences (TLSI), TELA Bio (TELA), Fractyl Health (GUTS), FONAR (FONR), Edap Tms (EDAP), LENSAR (LNSR), and Vivani Medical (VANI). These companies are all part of the "medical equipment" industry.

Beyond Air vs.

DarioHealth (NASDAQ:DRIO) and Beyond Air (NASDAQ:XAIR) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, valuation, analyst recommendations, institutional ownership, media sentiment, community ranking, profitability, risk and earnings.

DarioHealth currently has a consensus price target of $4.00, suggesting a potential upside of 412.82%. Beyond Air has a consensus price target of $3.67, suggesting a potential upside of 645.86%. Given Beyond Air's higher probable upside, analysts clearly believe Beyond Air is more favorable than DarioHealth.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
DarioHealth
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
Beyond Air
0 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
1 Strong Buy rating(s)
3.00

DarioHealth has a net margin of -205.62% compared to Beyond Air's net margin of -2,369.17%. DarioHealth's return on equity of -72.16% beat Beyond Air's return on equity.

Company Net Margins Return on Equity Return on Assets
DarioHealth-205.62% -72.16% -40.74%
Beyond Air -2,369.17%-227.29%-106.51%

DarioHealth has higher revenue and earnings than Beyond Air. DarioHealth is trading at a lower price-to-earnings ratio than Beyond Air, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
DarioHealth$20.35M1.31-$59.43M-$0.94-0.83
Beyond Air$1.16M30.59-$60.24M-$1.41-0.35

DarioHealth has a beta of 1.51, suggesting that its stock price is 51% more volatile than the S&P 500. Comparatively, Beyond Air has a beta of -0.18, suggesting that its stock price is 118% less volatile than the S&P 500.

In the previous week, Beyond Air had 5 more articles in the media than DarioHealth. MarketBeat recorded 5 mentions for Beyond Air and 0 mentions for DarioHealth. Beyond Air's average media sentiment score of 0.55 beat DarioHealth's score of 0.00 indicating that Beyond Air is being referred to more favorably in the news media.

Company Overall Sentiment
DarioHealth Neutral
Beyond Air Positive

33.4% of DarioHealth shares are owned by institutional investors. Comparatively, 31.5% of Beyond Air shares are owned by institutional investors. 16.5% of DarioHealth shares are owned by insiders. Comparatively, 20.1% of Beyond Air shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

DarioHealth received 190 more outperform votes than Beyond Air when rated by MarketBeat users. However, 69.57% of users gave Beyond Air an outperform vote while only 67.04% of users gave DarioHealth an outperform vote.

CompanyUnderperformOutperform
DarioHealthOutperform Votes
238
67.04%
Underperform Votes
117
32.96%
Beyond AirOutperform Votes
48
69.57%
Underperform Votes
21
30.43%

Summary

DarioHealth and Beyond Air tied by winning 9 of the 18 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

XAIR vs. The Competition

MetricBeyond AirSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$35.49M$4.41B$5.01B$8.81B
Dividend YieldN/A41.16%5.16%4.06%
P/E Ratio-0.3524.82134.3717.77
Price / Sales30.5947.021,158.6875.18
Price / CashN/A51.8733.5332.53
Price / Book0.664.974.674.68
Net Income-$60.24M$13.76M$119.07M$226.08M
7 Day Performance-7.25%-1.08%-1.83%-1.04%
1 Month Performance36.94%0.58%-3.62%1.04%
1 Year Performance-68.69%50.91%31.63%26.28%

Beyond Air Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
XAIR
Beyond Air
4.5392 of 5 stars
$0.49
-5.8%
$3.67
+645.9%
-69.1%$35.49M$1.16M-0.3570Gap Down
DRIO
DarioHealth
1.8622 of 5 stars
$0.78
-1.3%
$4.00
+412.8%
-31.6%$26.60M$20.35M-0.83200
PAVM
PAVmed
3.9842 of 5 stars
$1.03
+1.0%
$21.00
+1,938.8%
-68.7%$11.29M$2.45M0.0090Gap Down
SRTS
Sensus Healthcare
4.0682 of 5 stars
$8.94
+6.8%
$12.50
+39.8%
+331.9%$137.09M$24.41M15.6840Analyst Forecast
Analyst Revision
High Trading Volume
TLSI
TriSalus Life Sciences
4.2803 of 5 stars
$4.07
-1.2%
$12.08
+196.9%
+9.1%$125.62M$18.51M0.00106
TELA
TELA Bio
3.7058 of 5 stars
$2.90
-0.3%
$9.25
+219.0%
-40.5%$114.62M$58.45M0.00120
GUTS
Fractyl Health
1.6272 of 5 stars
$2.06
-5.9%
$22.00
+968.0%
N/A$99.09M$120,000.00-0.17102
FONR
FONAR
1.9578 of 5 stars
$14.89
+0.9%
N/A-18.3%$93.41M$102.01M10.64480
EDAP
Edap Tms
2.4619 of 5 stars
$2.45
+2.5%
$19.00
+675.5%
-45.7%$90.90M$65.42M-4.08307Analyst Downgrade
LNSR
LENSAR
2.1504 of 5 stars
$7.28
-2.5%
$8.00
+9.9%
+237.0%$86.76M$42.16M0.00110Positive News
VANI
Vivani Medical
3.1093 of 5 stars
$1.29
flat
$3.00
+132.6%
+35.6%$76.41MN/A-2.8720

Related Companies and Tools


This page (NASDAQ:XAIR) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners